Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Date of authorisation: 20/01/2025, Revision: 3, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 March 2026 - 13:28

Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Date of authorisation: 20/01/2025, Revision: 3, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/lazcluze

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters